Texas State Representative Diego Bernal says its the wrong approach to reviewing school safety following the Robb Elementary shooting.... Read more.

The Regional Aviation Enforcement Unit HH-1H Huey was doing training about 4 p.m. on June 4 near the Peterson Mountain range north of Cold Springs when it had a hard landing.... Read more.

A former San Francisco 49ers safety is the perfect free-agent fit for the Atlanta Falcons.... Read more.

Texas gun safety advocates demand common-sense gun legislation after recent mass shootings - FOX 29... Read more.

Texas State Representative Diego Bernal says its the wrong approach to reviewing school safety following the Robb Elementary shooting, calling it a 'terrible idea.'... Read more.

Opinion | For some Afghan refugees, there is no safety net - The Washington Post... Read more.

As migrant Kashmiri Pandit and Dogra employees have been demanding the government to shift them out of the Valley in the wake of targeted killings, t... Read more.

MADISON (WKOW) -- As Wisconsin lawmakers debate how to protect students nearly two weeks after a gunman killed 19 students and two staff members in a Texas elementary school, Republicans... Read more.

Senator Collins is part of a bipartisan group of Senators led by Chris Murphy (D-CT) that has been meeting to find consensus on gun safety legislation.... Read more.

SAN FRANCISCO (KRON) — KRON 4 Anchor Stephanie Lin sits down Berkeley mayor Jesse Arregu�n on his plans to improve public safety in the wake of a mass shooting threat at a local high school. Last week, KRON4 reported that a teen boy was arrested after he was recruiting other high school students to participate […]... Read more.

The Fairfax-San Anselmo Children's Center might have to vacate its site following an inspection that found potential hazards.... Read more.

SAN FRANCISCO (KRON) — KRON 4 Anchor Stephanie Lin spoke with Tommy Gong, Contra Costa County Deputy County Clerk-Recorder about ballot safety, voter turnout, and key deadlines in advance of the primary elections. California’s primary election will be on June 7. Tune into KRON4 or KRON On on Tuesday for all-day coverage.... Read more.

Treatment with larotrectinib elicited robust and durable responses, had a favorable safety profile, and sustained survival benefit in patients with central nervous system TRK fusion cancers.... Read more.

CYT - 0851 Phase 1 Dose Escalation Results Show Early Clinical Activity and Generally Well Tolerated Safety Profile in Advanced Solid Tumors and Hematologic Malignancies... Read more.

COIMBATORE The dumping and burning of garbage on a landfill at Chinniyampalayam off Avinashi Road... Read more.

Attendees learned Thursday morning all about the accomplishments and personal attributes that made each recipient deserving of their respective awards. Here are their stories:... Read more.

Helmets on Kids provides 250 young cyclists with free head gear... Read more.

Data showing the safety and efficacy of sellpercatinib for patients with solid tumors continues to impress clinicians at the 2022 ASCO Annual Meeting.... Read more.

Induction therapy with the quadruplet regimen of daratumumab, carfilzomib, lenalidomide, and dexamethasone appears to be feasible in patients with high-risk, newly diagnosed multiple myeloma who are eligible for transplant, displaying safety benefits and responses.... Read more.

World Food Safety Day 2022:�Every year on World Food Day, we take a moment to reflect on the global food system, and to remember the people... Read more.

Type 2 diabetes mellitus is a prevalent metabolic disease requiring tight glycemic control of basal and postprandial glucose levels. Treatment intensification using separate basal and bolus injections increased the number of injections and reduced cost-effectivity, leading to decreased compliance and failure of glycemic control. Insulin Degludec/Insulin Aspart (IDegAsp), a novel premix of basal and bolus insulin, is one of the potential treatments for reducing the number of injections. However, its efficacy and safety have not been reviewed clearly. Therefore, this systematic review aims to compare the efficacy and safety of IDegAsp with standard basal and basal plus bolus insulin regimens. A systematic review of four databases (Pubmed, Scopus, Science Direct, and Proquest) was conducted using the�Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. Search results were screened by eligibility criteria and critically appraised by the Oxford Centre for Evidence-Based Medicine (CEBM) tool and the Cochrane risk-of-bias assessment tool. Meta-Analysis was done using Review Manager to obtain cumulative outcomes from hemoglobin A1C (HbA1C) changes, hypoglycemia incidents, and weight gain from all studies. Out of 132 search results, 10 studies were reviewed. IDegAsp once-daily administration was proven beneficial in reducing HbA1c levels and nocturnal hypoglycemia incidences, while IDegAsp twice-daily administration was proven beneficial in lowering hypoglycemia incidence and nocturnal hypoglycemia incidence. IDegAsp yielded better glycemic index results and lowered hypoglycemic incidents in the meta-analysis. Thus, it is concluded that IDegAsp once daily with stepwise titration on the largest meal of the day achieved most benefits with minimal risks.... Read more.